Rigel Pharmaceuticals | RIGL - Interest Income


Rigel Pharmaceuticals reported $0.7 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Arrowhead Research USD 9.05M 1.97M Sep/2025
AstraZeneca USD 85M 17M Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 3.87M 2.25M Sep/2025
MacroGenics USD 1.53M 114K Sep/2025
Pfizer USD 0.62 156M Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Ultragenyx Pharmaceutical USD 5.86M 69K Sep/2025
Veracyte USD 3.48M 545K Sep/2025